N
Nest Genomics
Making genetic testing mainstream and integrated into patient care is difficult, Â Nest makes it easy
About Nest Genomics
Nest Genomics is a health-tech startup that operates in the medical genomics space. The company's primary focus is to support both patients and clinicians throughout the healthcare process, from identifying patients and educating them, to ordering tests and integrating results. Nest Genomics' services are designed to fit seamlessly into existing healthcare workflows and can be integrated with Electronic Medical Records (EMR), a digital version of a patient's paper chart.
The company's business model revolves around providing clinical decision support for healthcare providers, such as doctors and nurses, and equipping patients with the knowledge and tools they need to actively participate in their own care. This is achieved through the use of genetic counselors, who are healthcare professionals with specialized training in medical genetics and counseling.
Nest Genomics operates in a market that includes hospitals, clinics, and other healthcare organizations. They generate revenue by charging these organizations for their services, which are available across various medical specialties.
In summary, Nest Genomics is a healthcare startup that leverages genomics to improve patient care. They provide a platform that supports clinicians in making informed decisions and empowers patients with the knowledge to actively participate in their care.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2022
- Headquarters
- New York City, United States
- Employees
- 17
- Open positions
- None listed
- Dealroom signal
- 77.7/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology
- Sector
- Biotech & Life Sciences, YC W22, Hard Tech, science-based, DT and LS, Biotech and Pharma, Biotechnology
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SEED✓Equity / VC | Jan 2023 | $8.5M | $34M | LionBird · Samsung Next · Y Combinator · Casdin Capital | ↗ |
| SEED✓Equity / VC | Aug 2022 | $125K | $500K | Y Combinator | — |
Growth signals
Latest recorded traffic for Nest Genomics is 9.6K monthly website visits, up 209.7% over the last three months. Nest Genomics's team grew 21.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed9 investors entered at this stage
Y Combinator
LionBird
Samsung Next
Casdin Capital
DCVC
Anne Wojcicki
B Capital
iAngels
A-Squared Ventures
Other known investors7 additional known investors
Ali Tamaseb
Alumni Ventures
Arkin Capital
Endless Frontier Labs
Karen Page
Pioneer Fund
Towerview Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Nest Genomics on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Nest Genomics’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.